Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...
Good morning! Pharma companies are on a biotech buying spree, an LSD pill just delivered unusually strong late-stage ...
Regencell Bioscience Holdings Limited (RGC) focuses on TCM-based treatments for ADHD and Autism, targeting significant ...
GURU Nayagam PP guides aspirants on how to pick the right career course and college based on their entrance scores and ...
A new study provides the first insights into how thylakoid membranes—the internal compartments where oxygen-producing ...
This could be a key move for future growth.
Delhi University has initiated the admission process for one-year postgraduate (PG) courses for the 2026-27 academic session.
In a Q&A, Kenneth Chien, no longer with Moderna, predicts the company's mRNA cancer vaccine will be transformative for ...
The company faces a long road ahead if it hopes to stand out in the crowded obesity development scene, and iBio’s significant change in course in recent years could heap further scrutiny on the ...
Brandon Capital, Australasia’s leading life sciences venture capital firm, today announces the successful exit of its ...
In a major reform aimed at standardising postgraduate medical education in the country, the National Medical Commission (NMC) ...
Mornings like we had on Wednesday are exactly why I get up and do this show every single day the market is open. UniQure NV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results